世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
咳止めシロップ市場。世界の産業動向、シェア、サイズ、成長、機会、予測2021-2026年Cough Syrup Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global cough syrup market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 4% during 2021-2026. Keeping in mind the uncertainties... もっと見る
サマリーThe global cough syrup market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.Cough syrup is a combination drug that is used to provide temporary relief from cough, common cold, hay fever and other respiratory allergies. It is manufactured using non-opioid cough suppressants, expectorants and antihistamine compounds to block the symptoms. The suppressants aid in alleviating the symptoms of dry cough by minimizing the activity of the cough reflex and reducing the urge to cough. The expectorants aid in treating cough with mucus by loosening the mucus, thereby making it easier to expel from the body. The antihistamines are used to relieve cough caused by minor throat or airway irritation. Cough syrups are usually prescribed by doctors or are available over-the-counter (OTC) in pharmacy stores in a wide variety of flavors, such as cherry, orange, honey and bubblegum. Cough Syrup Market Trends: The increasing prevalence of upper respiratory tract infection (URTI) and other respiratory disorders across the globe is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Cough syrup is primarily used for the treatment of dry cough developed due to the prolonged exposure to poor air quality, tobacco and indoor smoke and air pollution. In line with this, the rising health consciousness among the masses and convenient product availability in pharmacies and general stores are also contributing to the growth of the market. Additionally, various product innovations, such as the development of cough syrups with minimal side effects, are acting as other growth-inducing factors. Product manufacturers are developing variants fortified with natural herbs and ingredients with immunity-boosting effects. Other factors, including rising expenditure capacities of the consumers, along with significant growth in the pharmaceutical industry, are anticipated to drive the market toward growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global cough syrup market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product type, age group and distribution channel. Breakup by Product Type: Expectorants Cough Suppressants/Antitussives Combination Medications Breakup by Age Group: Pediatric Adult Breakup by Distribution Channel: Retail Pharmacy Hospital Pharmacy Online Pharmacy Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Acella Pharmaceuticals LLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Prestige Consumer Healthcare Inc., Reckitt Benckiser Group PLC, Sanofi, Sun Pharmaceutical Industries Limited and The Procter & Gamble Company. Key Questions Answered in This Report: How has the global cough syrup market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global cough syrup market? What are the key regional markets? What is the breakup of the market based on the product type? What is the breakup of the market based on the age group? What is the breakup of the market based on the distribution channel? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global cough syrup market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Cough Syrup Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product Type 6.1 Expectorants 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Cough Suppressants/Antitussives 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Combination Medications 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Age Group 7.1 Pediatric 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Adult 7.2.1 Market Trends 7.2.2 Market Forecast 8 Market Breakup by Distribution Channel 8.1 Retail Pharmacy 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Hospital Pharmacy 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Online Pharmacy 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Acella Pharmaceuticals LLC 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.2 Bayer AG 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.3 GlaxoSmithKline PLC 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.3.4 SWOT Analysis 14.3.4 Johnson & Johnson 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Pfizer Inc. 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.5.4 SWOT Analysis 14.3.6 Prestige Consumer Healthcare Inc. 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.6.4 SWOT Analysis 14.3.7 Reckitt Benckiser Group PLC 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.7.4 SWOT Analysis 14.3.8 Sanofi 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 Financials 14.3.8.4 SWOT Analysis 14.3.9 Sun Pharmaceutical Industries Limited 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.9.3 Financials 14.3.9.4 SWOT Analysis 14.3.10 The Procter & Gamble Company 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.10.4 SWOT Analysis
SummaryThe global cough syrup market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.Cough syrup is a combination drug that is used to provide temporary relief from cough, common cold, hay fever and other respiratory allergies. It is manufactured using non-opioid cough suppressants, expectorants and antihistamine compounds to block the symptoms. The suppressants aid in alleviating the symptoms of dry cough by minimizing the activity of the cough reflex and reducing the urge to cough. The expectorants aid in treating cough with mucus by loosening the mucus, thereby making it easier to expel from the body. The antihistamines are used to relieve cough caused by minor throat or airway irritation. Cough syrups are usually prescribed by doctors or are available over-the-counter (OTC) in pharmacy stores in a wide variety of flavors, such as cherry, orange, honey and bubblegum. Cough Syrup Market Trends: The increasing prevalence of upper respiratory tract infection (URTI) and other respiratory disorders across the globe is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Cough syrup is primarily used for the treatment of dry cough developed due to the prolonged exposure to poor air quality, tobacco and indoor smoke and air pollution. In line with this, the rising health consciousness among the masses and convenient product availability in pharmacies and general stores are also contributing to the growth of the market. Additionally, various product innovations, such as the development of cough syrups with minimal side effects, are acting as other growth-inducing factors. Product manufacturers are developing variants fortified with natural herbs and ingredients with immunity-boosting effects. Other factors, including rising expenditure capacities of the consumers, along with significant growth in the pharmaceutical industry, are anticipated to drive the market toward growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global cough syrup market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product type, age group and distribution channel. Breakup by Product Type: Expectorants Cough Suppressants/Antitussives Combination Medications Breakup by Age Group: Pediatric Adult Breakup by Distribution Channel: Retail Pharmacy Hospital Pharmacy Online Pharmacy Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Acella Pharmaceuticals LLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Prestige Consumer Healthcare Inc., Reckitt Benckiser Group PLC, Sanofi, Sun Pharmaceutical Industries Limited and The Procter & Gamble Company. Key Questions Answered in This Report: How has the global cough syrup market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global cough syrup market? What are the key regional markets? What is the breakup of the market based on the product type? What is the breakup of the market based on the age group? What is the breakup of the market based on the distribution channel? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global cough syrup market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Cough Syrup Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product Type 6.1 Expectorants 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Cough Suppressants/Antitussives 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Combination Medications 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Age Group 7.1 Pediatric 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Adult 7.2.1 Market Trends 7.2.2 Market Forecast 8 Market Breakup by Distribution Channel 8.1 Retail Pharmacy 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Hospital Pharmacy 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Online Pharmacy 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Acella Pharmaceuticals LLC 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.2 Bayer AG 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.3 GlaxoSmithKline PLC 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.3.4 SWOT Analysis 14.3.4 Johnson & Johnson 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Pfizer Inc. 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.5.4 SWOT Analysis 14.3.6 Prestige Consumer Healthcare Inc. 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.6.4 SWOT Analysis 14.3.7 Reckitt Benckiser Group PLC 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.7.4 SWOT Analysis 14.3.8 Sanofi 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 Financials 14.3.8.4 SWOT Analysis 14.3.9 Sun Pharmaceutical Industries Limited 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.9.3 Financials 14.3.9.4 SWOT Analysis 14.3.10 The Procter & Gamble Company 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.10.4 SWOT Analysis
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（産業機械）の最新刊レポート
IMARC Services Private Limited.社のその他分野での最新刊レポート
本レポートと同じKEY WORD（industry）の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |
